image: Dr. Gretchen Diehl is the corresponding author of this work. view more
Credit: Baylor College of Medicine
New research reveals a cellular mechanism by which good bacteria can help the gut stay healthy. The study, which appears in the journal Immunity, shows that good bacteria, or the microbiota, interact with both the epithelial cells lining the gut and cells of the immune system to help balance the immune responses and protect the gut from unwanted inflammation. The study suggests that manipulating the microbiota to limit intestinal immune responses could have potential therapeutic benefits for conditions such as inflammatory bowel disease.
"A significant body of work currently indicates that the microbiota shapes the immune system and helps it to do its job," said corresponding author Dr. Gretchen Diehl, assistant professor of molecular virology and microbiology co-director of the Biology of Inflammation Center and a member of the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine. "Disease-causing microbes, such as Salmonella, evoke a strong inflammatory immune response that is directed at eliminating the microbe. But an inflammatory immune response, especially in the intestine, can be damaging to the healthy tissue. Here we defined a role for the microbiota in modulating the immune response in a way that reduces inflammation and limits the damage it can do to the gut."
For an effective immune response, immune cells called antigen-presenting cells direct other immune cells, called T cells, to mount an appropriate inflammatory response to fight microbial invaders. They also direct anti-inflammatory T cells, also known as regulatory T cells, to limit inflammatory immune responses against things like the food we eat and to turn off inflammatory immune responses.
The microbiota helps 'tune down' the inflammatory response by instructing the antigen-presenting cells to secrete the cytokine IL-10, an important anti-inflammatory molecule. IL-10 dampens inflammatory T cell responses and promotes regulatory T cell responses that keep the balance.
"The result is a balanced response that still can fight off an infection like Salmonella, but that is regulated to prevent damage to the healthy intestinal tissue," Diehl said. "We wanted to know how the microbiota could induce these kind of responses."
The microbiota-epithelium connection
"We found that when we gave the laboratory animals antibiotics, the antigen-presenting cells did not make IL-10. When we put back bacteria in the animals' guts, only bacteria that could attach to the intestinal epithelium triggered IL-10 production by antigen-presenting cells and reduced the inflammatory response," Diehl said. "It's somewhat counterintuitive because microbes that can attach to the intestinal epithelium are thought of as pathogens that can potentially cause disease. But in this case we found that the attachment of bacteria to the epithelium was not causing disease; on the contrary, it was necessary to promote a balanced regulation of the T cell responses and helped protect the gut."
The researchers indicate that their study is barely scratching the surface, and they are actively looking for other mechanisms by which microbes can promote a well-balanced intestinal environment.
Next, Diehl and her colleagues also plan on investigating the signaling pathways that are activated when the microbes attach to the epithelial cells to identify novel pathways for inducing a balanced immune response.
"A take home message for us is that a healthy microbiota is necessary to allow for a balanced response to not only protect us from infection, but also to limit potential tissue damage as the immune system attempts to eliminate pathogens," Diehl said.
###
Other contributors to this work include Myunghoo Kim, Carolina Galan, Andrea A. Hill, Wan-Jung Wu, Hannah Fehlner-Peach, Hyo Won Song, Deborah Schady, Matthew L. Bettini, Kenneth W. Simpson, Randy S. Longman and Dan R. Littman. The authors are affiliated with one or more of the following institutions: Baylor College of Medicine, New York University School of Medicine, University of Massachusetts Medical School, Texas Children's Hospital, Cornell University, Weill Cornell Medicine and the Howard Hughes Medical Institute.
This study was supported by funding from the Curtis Hankamer Basic Research Fund at Baylor College of Medicine, the Texas Medical Center Digestive Disease Center Pilot Fund P30 DK056338 and National Institutes of Health grants AI123945, AI125264 and DK114252. Additional support was provided by the National Research Service Award T32AI053831_Corry, AAI Careers in Immunology Fellowship, the Howard Hughes Medical Institute, the Colton Center for Autoimmunity, the Texas Medical Center Digestive Disease Center Cellular and Molecular Morphology Core with funding from the NIH (P30DK056338) and the Cytometry and Cell Sorting Core at Baylor College of Medicine with funding from the NIH (P30 AI036211, P30 CA125123, and S10 RR024574).
Journal
Immunity